ATG16L1 expression in carotid atherosclerotic plaques is associated with plaque vulnerability

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 5, 2015, Pages 1226-1235

  Magné, Joëlle ^a   Gustafsson, Peter ^a   Jin, Hong ^a   Maegdefessel, Lars ^a   Hultenby, Kjell ^b   Wernerson, Annika ^b   Eriksson, Per ^a   Franco Cereceda, Anders ^b   Kovanen, Petri T ^c   Gonçalves, Isabel ^d   Ehrenborg, Ewa ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c WIHURI RESEARCH INSTITUTE   (Finland)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ATG16L1; atherosclerosis; autophagy; carotid plaque

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CD31 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHOLESTEROL; GELATINASE A; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN; PROTEIN ATG16L1; RANTES; STROMELYSIN 2; TRIACYLGLYCEROL; TRYPTASE; UNCLASSIFIED DRUG; ATG16L1 PROTEIN, HUMAN; CARRIER PROTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROGENESIS; AUTOPHAGY; CAROTID ARTERY; CAROTID ARTERY THROMBOSIS; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; FEMALE; FOAM CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGOLD LABELING; INFLAMMATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MAST CELL; MOUSE; MURINE MODEL; NONHUMAN; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; CAROTID STENOSIS; CELL CULTURE; DISEASE COURSE; EPIDEMIOLOGY; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOPTOSIS; AUTOPHAGY; CAROTID STENOSIS; CARRIER PROTEINS; CELLS, CULTURED; DISEASE PROGRESSION; ENDARTERECTOMY, CAROTID; ENDOTHELIAL CELLS; FEMALE; FOAM CELLS; GENE EXPRESSION REGULATION; HUMANS; MALE; MAST CELLS; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84933074128     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304840     Document Type: Article

References (34)

1. Choi AM, Ryter SW, Levine B, Autophagy in human health and disease. N Engl J Med 2013 368 1845 1846. doi: 10.1056/NEJMc1303158
2. Singh R, Cuervo AM, Autophagy in the cellular energetic balance. Cell Metab 2011 13 495 504. doi: 10.1016/j.cmet.2011.04.004
3. Yang Z, Klionsky DJ, Eaten alive: a history of macroautophagy. Nat Cell Biol 2010 12 814 822. doi: 10.1038/ncb0910-814
4. Kaufmann A, Beier V, Franquelim HG, Wollert T, Molecular mechanism of autophagic membrane-scaffold assembly and disassembly. Cell 2014 156 469 481. doi: 10.1016/j.cell.2013.12.022
5. Nishimura T, Kaizuka T, Cadwell K, Sahani MH, Saitoh T, Akira S, Virgin HW, Mizushima N, FIP200 regulates targeting of Atg16L1 to the isolation membrane. EMBO Rep 2013 14 284 291. doi: 10.1038/embor.2013.6
6. Hampe J, Franke A, Rosenstiel P, A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007 39 207 211. doi: 10.1038/ng1954
7. Bentzon JF, Otsuka F, Virmani R, Falk E, Mechanisms of plaque formation and rupture. Circ Res 2014 114 1852 1866. doi: 10.1161/CIRCRESAHA.114.302721
8. Martinet W, De Meyer GR, Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res 2009 104 304 317. doi: 10.1161/CIRCRESAHA.108.188318
9. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J, Tabas I, Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012 15 545 553. doi: 10.1016/j.cmet.2012.01.022
10. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, Ting JP, Virgin HW, Kastan MB, Semenkovich CF, Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 2012 15 534 544. doi: 10.1016/j.cmet.2012.02.011
11. Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL, Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab 2011 13 655 667. doi: 10.1016/j.cmet.2011.03.023
12. De Meyer I, Martinet W, Schrijvers DM, Timmermans JP, Bult H, De Meyer GR, Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques. Basic Res Cardiol 2012 107 269. doi: 10.1007/s00395-012-0269-1
13. Verheye S, Martinet W, Kockx MM, Knaapen MW, Salu K, Timmermans JP, Ellis JT, Kilpatrick DL, De Meyer GR, Selective clearance of macrophages in atherosclerotic plaques by autophagy. J Am Coll Cardiol 2007 49 706 715. doi: 10.1016/j.jacc.2006.09.047
14. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Genereux P, Branzi A, Stone GW, Stent thrombosis with drug-eluting stents: is the paradigm shifting? J Am Coll Cardiol 2013 62 1915 1921. doi: 10.1016/j.jacc.2013.08.725
15. Martinet W, Verheye S, De Meyer I, Timmermans JP, Schrijvers DM, Van Brussel I, Bult H, De Meyer GR, Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid. Arterioscler Thromb Vasc Biol 2012 32 1228 1235. doi: 10.1161/ATVBAHA.112.245381
16. Martinet W, De Loof H, De Meyer GR, mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis 2014 233 601 607. doi: 10.1016/j.atherosclerosis.2014.01.040
17. Murthy A, Li Y, Peng I, Reichelt M, Katakam AK, Noubade R, Roose-Girma M, DeVoss J, Diehl L, Graham RR, van Lookeren Campagne M, A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3. Nature 2014 506 456 462. doi: 10.1038/nature13044
18. Lassen KG, Kuballa P, Conway KL, Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc Natl Acad Sci U S A 2014 111 7741 7746. doi: 10.1073/pnas.1407001111
19. Sergin I, Razani B, Self-eating in the plaque: what macrophage autophagy reveals about atherosclerosis. Trends Endocrinol Metab 2014 25 225 234. doi: 10.1016/j.tem.2014.03.010
20. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Shibata T, Sato K, Iguchi A, A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006 26 1304 1309. doi: 10.1161/01.ATV.0000219687.71607.f7
21. Klionsky DJ, Abdalla FC, Abeliovich H, Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012 8 445 544
22. Hansson GK, Hermansson A, The immune system in atherosclerosis. Nat Immunol 2011 12 204 212. doi: 10.1038/ni.2001
23. Levine B, Mizushima N, Virgin HW, Autophagy in immunity and inflammation. Nature 2011 469 323 335. doi: 10.1038/nature09782
24. Plantinga TS, Crisan TO, Oosting M, van de Veerdonk FL, de Jong DJ, Philpott DJ, van der Meer JW, Girardin SE, Joosten LA, Netea MG, Crohn's disease-Associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut 2011 60 1229 1235. doi: 10.1136/gut.2010.228908
25. Saitoh T, Fujita N, Jang MH, Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008 456 264 268. doi: 10.1038/nature07383
26. Willems S, Vink A, Bot I, Quax PH, de Borst GJ, de Vries JP, van de Weg SM, Moll FL, Kuiper J, Kovanen PT, de Kleijn DP, Hoefer IE, Pasterkamp G, Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events. Eur Heart J 2013 34 3699 3706. doi: 10.1093/eurheartj/eht186
27. Bot I, Shi GP, Kovanen PT, Mast cells as effectors in atherosclerosis. Arterioscler Thromb Vasc Biol 2015 35 265 271. doi: 10.1161/ATVBAHA.114.303570
28. Ushio H, Ueno T, Kojima Y, Crucial role for autophagy in degranulation of mast cells. J Allergy Clin Immunol 2011 127 1267 76.e6. doi: 10.1016/j.jaci.2010.12.1078
29. Romao S, Münz C, LC3-Associated phagocytosis. Autophagy 2014 10 526 528. doi: 10.4161/auto.27606
30. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA, Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 2014 129 1551 1559. doi: 10.1161/CIRCULATIONAHA.113.005015
31. Salabei JK, Hill BG, Implications of autophagy for vascular smooth muscle cell function and plasticity. Free Radic Biol Med 2013 65 693 703. doi: 10.1016/j.freeradbiomed.2013.08.003
32. Gomez D, Owens GK, Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012 95 156 164. doi: 10.1093/cvr/cvs115
33. Silvestre-Roig C, de Winther MP, Weber C, Daemen MJ, Lutgens E, Soehnlein O, Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res 2014 114 214 226. doi: 10.1161/CIRCRESAHA.114.302355
34. Folco EJ, Sukhova GK, Quillard T, Libby P, Moderate hypoxia potentiates interleukin-1β production in activated human macrophages. Circ Res 2014 115 875 883. doi: 10.1161/CIRCRESAHA.115.304437